Related Experiment Videos
Rapidly progressive IgA nephropathy
Naho Kobayashi1, Masashi Nishida, Michiko Aoyama
1Department of Pediatric Cardiology, University of Medicine Graduate School of Medical Science, Kyoto, Japan.
Indian Journal of Pediatrics
|April 7, 2005
Summary
A rapidly progressive IgA nephropathy case in a 14-year-old boy showed remarkable recovery after high-dose corticosteroid treatment, despite initial adverse effects. This highlights potential therapeutic benefits in severe cases.
Area of Science:
- Nephrology
- Immunology
Background:
- IgA nephropathy (IgAN) is a common glomerular disease.
- Rapidly progressive IgAN (RP-IgAN) presents with severe renal function decline.
- Crescentic glomerulonephritis characterizes RP-IgAN, often leading to kidney failure.
Observation:
- A 14-year-old male presented with hematuria and acute kidney injury.
- Renal biopsy revealed severe crescentic IgA nephropathy with 88% crescents.
- Initial treatment with intravenous methylprednisolone caused significant nausea, malaise, and worsening renal markers (BUN, creatinine).
Findings:
- Despite initial adverse effects, renal function rapidly improved with continued oral corticosteroid therapy.
- Complete renal function recovery was achieved.
- The patient's response was notable compared to previously reported RP-IgAN cases.
Implications:
- High-dose corticosteroids may be effective in treating severe crescentic IgAN, even with initial complications.
- Careful monitoring and adjustment of treatment are crucial for managing adverse effects.
- This case underscores the potential for significant recovery in RP-IgAN with appropriate immunosuppressive therapy.